Cargando…

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD

One of the puzzling observations concerning mild cognitive impairment (MCI) and Alzheimer's disease (AD), is that many gene expressions in MCI may be in the opposite direction of those seen in AD. Several examples of this paradox are provided. The likely explanation lies in in the control mecha...

Descripción completa

Detalles Bibliográficos
Autor principal:	Fessel, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111579/ https://www.ncbi.nlm.nih.gov/pubmed/32258360 http://dx.doi.org/10.1002/trc2.12003

Ejemplares similares

Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
por: Pak, Victoria M., et al.
Publicado: (2020)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
por: Bryant, Annie G., et al.
Publicado: (2021)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
por: Gao, Fei, et al.
Publicado: (2020)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Brain signatures based on structural MRI: Classification for MCI, PMCI, and AD
por: Gonuguntla, Venkateswarlu, et al.
Publicado: (2022)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid
por: Luis, Cheryl A., et al.
Publicado: (2011)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD
por: Richter, Nils, et al.
Publicado: (2019)

Free Water in White Matter Differentiates MCI and AD From Control Subjects
por: Dumont, Matthieu, et al.
Publicado: (2019)

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
por: Bertens, Daniela, et al.
Publicado: (2019)

Cortical graph neural network for AD and MCI diagnosis and transfer learning across populations
por: Wee, Chong-Yaw, et al.
Publicado: (2019)

Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI
por: Carlson, Mackenzie L., et al.
Publicado: (2020)

Early MCI-to-AD Conversion Prediction Using Future Value Forecasting of Multimodal Features
por: Minhas, Sidra, et al.
Publicado: (2021)

Effects of White Matter Hyperintensities on Verbal Fluency in Healthy Older Adults and MCI/AD
por: Kaskikallio, Alar, et al.
Publicado: (2021)

A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD
por: McNett, Sienna D., et al.
Publicado: (2023)

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics
por: Varatharajah, Yogatheesan, et al.
Publicado: (2019)

Morphological Factor Estimation via High-Dimensional Reduction: Prediction of MCI Conversion to Probable AD
por: Duchesne, Simon, et al.
Publicado: (2011)

Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion
por: Li, Han, et al.
Publicado: (2014)

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data
por: Ye, Jieping, et al.
Publicado: (2012)

Assessment of PET & ASL metabolism in the hippocampal subfields of MCI and AD using simultaneous PET-MR
por: Goubran, Maged, et al.
Publicado: (2015)

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
por: Anderson, Eric D., et al.
Publicado: (2016)

Predicting Conversion from MCI to AD Combining Multi-Modality Data and Based on Molecular Subtype
por: Li, Hai-Tao, et al.
Publicado: (2021)

Multi-Modal Feature Selection with Feature Correlation and Feature Structure Fusion for MCI and AD Classification
por: Jiao, Zhuqing, et al.
Publicado: (2022)

Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time
por: Hendrix, Suzanne B
Publicado: (2012)

Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau
por: Dickerson, Bradford C., et al.
Publicado: (2013)

Exploration of time–frequency reassignment and homologous inter-hemispheric asymmetry analysis of MCI–AD brain activity
por: Nimmy John, T., et al.
Publicado: (2019)

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
por: Tao, Ye, et al.
Publicado: (2020)

In the Hands of Hypnos: Associations between Sleep, Cognitive Performance and Financial Capacity in aMCI and Mild AD
por: Giannouli, Vaitsa, et al.
Publicado: (2023)

Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator
por: Pang, Y., et al.
Publicado: (2023)

Citation Analysis of The Korean Journal of Internal Medicine from KoMCI, Web of Science, and Scopus
por: Huh, Sun
Publicado: (2011)

Inter-hemispheric functional dysconnectivity mediates the association of corpus callosum degeneration with memory impairment in AD and amnestic MCI
por: Qiu, Yingwei, et al.
Publicado: (2016)

PARP-1 and p53 Regulate the Increased Susceptibility to Oxidative Death of Lymphocytes from MCI and AD Patients
por: Salech, Felipe, et al.
Publicado: (2017)

Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
por: Brugnolo, Andrea, et al.
Publicado: (2021)

Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Found by Hierarchical Clustering
por: Kärkkäinen, Mikko, et al.
Publicado: (2020)

SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis
por: Sahrai, Hadi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e8j7hve7ndeqv1jehc4g13g5rd